1
Westra, Tjalke A., Daemen, Toos, Postma, Maarten J., Wilschut, Jan C.
Veröffentlicht in: Westra , T A , Daemen , T , Postma , M J & Wilschut , J C 2009 , ' Doelmatigheid van humaan papillomavirus-vaccinatie : Schattingen op basis van Nederlandse kosteneffectiviteitanalyses ' , Nederlands Tijdschrift voor Geneeskunde , vol. 153 , no. 45 , A356 . < https://www.ntvg.nl/artikelen/doelmatigheid-van-humaan-papillomavirus-vaccinatie#:~:text=Tenslotte%20blijkt%20uit%20de%205,%E2%82%AC20.000%20per%20gewonnen%20QALY. >;
2009
Veröffentlicht in: Westra , T A , Daemen , T , Postma , M J & Wilschut , J C 2009 , ' Doelmatigheid van humaan papillomavirus-vaccinatie : Schattingen op basis van Nederlandse kosteneffectiviteitanalyses ' , Nederlands Tijdschrift voor Geneeskunde , vol. 153 , no. 45 , A356 . < https://www.ntvg.nl/artikelen/doelmatigheid-van-humaan-papillomavirus-vaccinatie#:~:text=Tenslotte%20blijkt%20uit%20de%205,%E2%82%AC20.000%20per%20gewonnen%20QALY. >;
2009
2
Zeevat, Florian, Simons, Joost J.M., Westra, Tjalke A., Wilschut, Jan C., Boersma, Cornelis, Postma, Maarten J.
Veröffentlicht in: Zeevat , F , Simons , J J M , Westra , T A , Wilschut , J C , Boersma , C & Postma , M J 2024 , ' Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach ' , Infectious diseases and therapy . https://doi.org/10.1007/s40121-023-00903-0;
2024
Veröffentlicht in: Zeevat , F , Simons , J J M , Westra , T A , Wilschut , J C , Boersma , C & Postma , M J 2024 , ' Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach ' , Infectious diseases and therapy . https://doi.org/10.1007/s40121-023-00903-0;
2024
3
Westra, Tjalke A., Stirbu-Wagner, Irina, Dorsman, Sara, Tutuhatunewa, Eric D., de Vrij, Edwin L., Nijman, Hans W., Daemen, Toos, Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013